A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression
- PMID: 20671976
- PMCID: PMC2909727
- DOI: 10.1155/2010/428325
A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression
Abstract
We present a comprehensive study of cytogenetic alterations that occur during the progression of clear cell renal cell carcinoma (ccRCC). We used high-density high-throughput Affymetrix 100 K SNP arrays to obtain the whole genome SNP copy number information from 71 pretreatment tissue samples with RCC tumors; of those, 42 samples were of human ccRCC subtype. We analyzed patterns of cytogenetic loss and gain from different RCC subtypes and in particular, different stages and grades of ccRCC tumors, using a novel algorithm that we have designed. Based on patterns of cytogenetic alterations in chromosomal regions with frequent losses and gains, we inferred the involvement of candidate genes from these regions in ccRCC tumorigenesis and development. We then proposed a new model of ccRCC tumorigenesis and progression. Our study serves as a comprehensive overview of cytogenetic alterations in a collection of 572 ccRCC tumors from diversified studies and should facilitate the search for specific genes associated with the disease.
Figures





Similar articles
-
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.Dan Med J. 2017 Oct;64(10):B5339. Dan Med J. 2017. PMID: 28975890
-
Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.Eur Urol Focus. 2019 Jul;5(4):608-618. doi: 10.1016/j.euf.2018.01.016. Epub 2018 Feb 13. Eur Urol Focus. 2019. PMID: 29452772
-
Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.PLoS One. 2017 May 9;12(5):e0176659. doi: 10.1371/journal.pone.0176659. eCollection 2017. PLoS One. 2017. PMID: 28486536 Free PMC article.
-
Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.Cancer Biomark. 2010;7(6):261-8. doi: 10.3233/CBM-2010-0195. Cancer Biomark. 2010. PMID: 21694464 Review.
-
Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.Eur Radiol. 2020 Jul;30(7):4023-4038. doi: 10.1007/s00330-020-06740-w. Epub 2020 Mar 6. Eur Radiol. 2020. PMID: 32144458 Free PMC article.
Cited by
-
RCDB: Renal Cancer Gene Database.BMC Res Notes. 2012 May 18;5:246. doi: 10.1186/1756-0500-5-246. BMC Res Notes. 2012. PMID: 22608002 Free PMC article.
-
Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.Cancer Cell Int. 2020 Oct 6;20:482. doi: 10.1186/s12935-020-01585-1. eCollection 2020. Cancer Cell Int. 2020. PMID: 33041663 Free PMC article.
-
Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA.Oncotarget. 2017 Apr 25;8(17):28558-28574. doi: 10.18632/oncotarget.15331. Oncotarget. 2017. PMID: 28212566 Free PMC article.
-
Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.Histol Histopathol. 2012 Aug;27(8):975-84. doi: 10.14670/HH-27.975. Histol Histopathol. 2012. PMID: 22763871 Free PMC article. Review.
-
Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.J Thyroid Res. 2011;2011:361304. doi: 10.4061/2011/361304. Epub 2011 Jun 8. J Thyroid Res. 2011. PMID: 21760978 Free PMC article.
References
-
- Tan M-H, Rogers CG, Cooper JT, et al. Gene expression profiling of renal cell carcinoma. Clinical Cancer Research. 2004;10(18, part 2):6315S–6321S. - PubMed
-
- Cohen HT, McGovern FJ. Renal-cell carcinoma. The New England Journal of Medicine. 2005;353(23):2477–2490. - PubMed
-
- Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. The Science. 1993;260(5112):1317–1320. - PubMed
-
- Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. American Journal of Surgical Pathology. 2005;29(6):747–754. - PubMed
LinkOut - more resources
Full Text Sources